62 related articles for article (PubMed ID: 15797465)
1. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
Katsel PL; Davis KL; Haroutunian V
Int Rev Neurobiol; 2005; 63():41-82. PubMed ID: 15797465
[No Abstract] [Full Text] [Related]
2. Comprehensive Gene Expression Analysis Detects Global Reduction of Proteasome Subunits in Schizophrenia.
Hertzberg L; Maggio N; Muler I; Yitzhaky A; Majer M; Haroutunian V; Zuk O; Katsel P; Domany E; Weiser M
Schizophr Bull; 2021 Apr; 47(3):785-795. PubMed ID: 33141894
[TBL] [Abstract][Full Text] [Related]
3. Molecular signature of extracellular matrix pathology in schizophrenia.
Pantazopoulos H; Katsel P; Haroutunian V; Chelini G; Klengel T; Berretta S
Eur J Neurosci; 2021 Jun; 53(12):3960-3987. PubMed ID: 33070392
[TBL] [Abstract][Full Text] [Related]
4. Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword.
Diniz LP; Matias I; Siqueira M; Stipursky J; Gomes FCA
Mol Neurobiol; 2019 Jul; 56(7):4653-4679. PubMed ID: 30377983
[TBL] [Abstract][Full Text] [Related]
5. Peptides as Potential Therapeutics for Alzheimer's Disease.
Ribarič S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385735
[TBL] [Abstract][Full Text] [Related]
6. Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex.
Ersland KM; Skrede S; Stansberg C; Steen VM
Transl Psychiatry; 2017 Nov; 7(11):1262. PubMed ID: 29187753
[TBL] [Abstract][Full Text] [Related]
7. The Rationale for Insulin Therapy in Alzheimer's Disease.
Ribarič S
Molecules; 2016 May; 21(6):. PubMed ID: 27240327
[TBL] [Abstract][Full Text] [Related]
8. Role of TGFβ signaling in the pathogenesis of Alzheimer's disease.
von Bernhardi R; Cornejo F; Parada GE; Eugenín J
Front Cell Neurosci; 2015; 9():426. PubMed ID: 26578886
[TBL] [Abstract][Full Text] [Related]
9. Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.
Borjabad A; Volsky DJ
J Neuroimmune Pharmacol; 2012 Dec; 7(4):914-26. PubMed ID: 23065460
[TBL] [Abstract][Full Text] [Related]
10. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
Ginsberg SD; Alldred MJ; Che S
Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
[TBL] [Abstract][Full Text] [Related]
11. Gene expression reveals overlap between normal aging and Alzheimer's disease genes.
Avramopoulos D; Szymanski M; Wang R; Bassett S
Neurobiol Aging; 2011 Dec; 32(12):2319.e27-34. PubMed ID: 20570407
[TBL] [Abstract][Full Text] [Related]
12. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
[TBL] [Abstract][Full Text] [Related]
13. Target identification for CNS diseases by transcriptional profiling.
Altar CA; Vawter MP; Ginsberg SD
Neuropsychopharmacology; 2009 Jan; 34(1):18-54. PubMed ID: 18923405
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiles of schizophrenia in the CNS at different stages of illness.
Narayan S; Tang B; Head SR; Gilmartin TJ; Sutcliffe JG; Dean B; Thomas EA
Brain Res; 2008 Nov; 1239():235-48. PubMed ID: 18778695
[TBL] [Abstract][Full Text] [Related]
15. Glial cell dysregulation: a new perspective on Alzheimer disease.
von Bernhardi R
Neurotox Res; 2007 Dec; 12(4):215-32. PubMed ID: 18201950
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.
Haroutunian V; Katsel P; Schmeidler J
Neurobiol Aging; 2009 Apr; 30(4):561-73. PubMed ID: 17845826
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.
Buxbaum JD; Georgieva L; Young JJ; Plescia C; Kajiwara Y; Jiang Y; Moskvina V; Norton N; Peirce T; Williams H; Craddock NJ; Carroll L; Corfas G; Davis KL; Owen MJ; Harroch S; Sakurai T; O'Donovan MC
Mol Psychiatry; 2008 Feb; 13(2):162-72. PubMed ID: 17579610
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.
Thomas EA
Mol Neurobiol; 2006 Oct; 34(2):109-28. PubMed ID: 17220533
[TBL] [Abstract][Full Text] [Related]
19. Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.
Youdim MB; Amit T; Bar-Am O; Weinreb O; Yogev-Falach M
Neurotox Res; 2006 Dec; 10(3-4):181-92. PubMed ID: 17197368
[TBL] [Abstract][Full Text] [Related]
20. Neuroanatomical phenotypes in the reeler mouse.
Badea A; Nicholls PJ; Johnson GA; Wetsel WC
Neuroimage; 2007 Feb; 34(4):1363-74. PubMed ID: 17185001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
